Johnson & Johnson’s one-dose COVID-19 vaccine has been accepted by the FDA.
The Food and Drug Administration has accepted a 3rd coronavirus vaccine to be used within the United States. Johnson & Johnson’s one-dose vaccine to fight the deadly virus that has killed over 500,000 people in the U.S. over the final 12 months shall be made accessible as quickly as attainable. Shipments of the primary few million doses are anticipated to exit Monday.
Michael Ciaglo / Getty Images
“This is really good news,” Dr. Francis Collins, director of the National Institutes of Health, advised The Associated Press Saturday. “The most important thing we can do right now is to get as many shots in as many arms as we can.”
J&J’s one-dose vaccine has been discovered to be 85% protecting in opposition to the strongest strains of COVID-19. The firm says 20 million doses are anticipated to be delivered by the top of March and 100 million by the beginning of summer season.
“This is exciting news for all Americans, and an encouraging development in our efforts to bring an end to the crisis,” President Joe Biden mentioned in a press release. “But I need to be clear: this battle is much from over.”
J&J continues to be searching for approval for emergency use in Europe and from the World Health Organization.